Published in Control Clin Trials on December 01, 2000
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ (2008) 2.10
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Ovarian cancer screening. CMAJ (2004) 1.52
Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer. AIMS Med Sci (2015) 0.77
Cancer screening trials: nuts and bolts. Semin Oncol (2010) 0.76
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials (2000) 6.17
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest (1973) 5.31
Detection of Australia antigen and antibody by means of radioimmunoassay techniques. J Infect Dis (1970) 3.89
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 3.29
pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest (1975) 3.07
Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther (2000) 2.96
Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet (1998) 2.74
A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med (1981) 2.59
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Pure human big gastrin. Immunochemical properties, disappearance half time, and acid-stimulating action in dogs. J Clin Invest (1974) 2.51
Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology (1973) 2.47
Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer. J Clin Invest (1975) 2.08
Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients. J Clin Invest (1980) 2.03
Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst (1987) 2.02
Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst (1987) 2.01
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut (1992) 1.94
Peroxisomal multifunctional beta-oxidation protein of Saccharomyces cerevisiae. Molecular analysis of the fox2 gene and gene product. J Biol Chem (1992) 1.88
Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst (1978) 1.87
Gastrin (first of two parts). N Engl J Med (1975) 1.85
The use of prognostic factors in predicting survival for breast cancer patients. J Chronic Dis (1966) 1.84
Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc (1999) 1.80
Zollinger-Ellison syndrome. Gastroenterology (1973) 1.79
Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med (1987) 1.73
Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients. Gastroenterology (1975) 1.68
The effect of atropine on plasma gastrin response to feeding. Gastroenterology (1971) 1.66
Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med (1979) 1.61
The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer. Gastroenterology (1976) 1.58
Clearance and acid-stimulating action of human big and little gastrins in duodenal ulcer subjects. J Clin Invest (1976) 1.57
The effect of an H2-receptor antagonist on food-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug. J Clin Invest (1975) 1.56
The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract. Neuroscience (1979) 1.56
Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest (1977) 1.55
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. Gastroenterology (1974) 1.51
Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology (1972) 1.50
Gastrin (second of two parts). N Engl J Med (1975) 1.49
A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med (1989) 1.48
Gastrin, CCK, signaling, and cancer. Annu Rev Physiol (2001) 1.44
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA (1970) 1.43
Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man. N Engl J Med (1973) 1.40
Studies on the mechanisms of food-stimulated gastric acid secretion in normal human subjects. J Clin Invest (1976) 1.40
Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. Gastroenterology (1992) 1.40
Effect of hamstring and psoas lengthening on pelvic tilt in patients with spastic diplegic cerebral palsy. J Pediatr Orthop (1999) 1.38
Black/white differences in bladder cancer patient survival. J Chronic Dis (1987) 1.38
The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology (1976) 1.37
Intractable diarrhea. Intestinal perfusion studies and plasma VIP concentrations in patients with pancreatic cholera syndrome and surreptitious ingestion of laxatives and diuretics. Am J Dig Dis (1977) 1.36
Pure human minigastrin: secretory potency and disappearance rate. Gut (1974) 1.36
Survival of children with brain tumors: SEER Program, 1973-1980. Neurology (1986) 1.36
Role of gastrin heptadecapeptide in the acid secretory response to amino acids in man. J Clin Invest (1978) 1.32
Cholecystokinin-octapeptidelike immunoreactivity in human plasma. Gastroenterology (1982) 1.29
The course of five-year survivors of cancer in childhood. J Pediatr (1978) 1.28
Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials (2000) 1.25
Bombesin-like peptides in mammals. Fed Proc (1979) 1.24
Amino acid sequences of three bombesin-like peptides from canine intestine extracts. J Biol Chem (1983) 1.23
Statistical methods for studying multiple primary malignant neoplasms. Cancer (1977) 1.23
Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet (1987) 1.22
Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs. Gastroenterology (1979) 1.22
Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide concentrations in humans. Gastroenterology (1980) 1.19
Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience (2002) 1.18
Similar acid stimulatory potencies of synthetic human big and little gastrins in man. J Clin Invest (1984) 1.18
Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.18
Trends in survival rates of patients with cancer. N Engl J Med (1975) 1.16
Regulation of gastric acid secretion. Annu Rev Physiol (1979) 1.16
Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J Epidemiol (1986) 1.16
Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset. Clin Exp Immunol (1993) 1.16
Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology (1978) 1.16
Effect of antral denervation on gastrin release by sham feeding and insulin hypoglycemia in dogs. Gastroenterology (1972) 1.14
Effect of truncal vagotomy on gastrin release and Heidenhain pouch acid secretion in response to feeding in dogs. Gastroenterology (1972) 1.12
Effects of atropine and of antral acidification on gastrin release and acid secretion in response to insulin and feeding in dogs. Gastroenterology (1972) 1.11
Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor. J Biol Chem (1999) 1.11
Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives. Med Pediatr Oncol (1988) 1.10
Implications from SEER data on breast cancer management. Cancer (1978) 1.09
The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. N Engl J Med (1986) 1.09
Hodgkin's disease in the United States: a comparison of patient characteristics and survival in the Centralized Cancer Patient Data System and the Surveillance, Epidemiology, and End Results Program. J Natl Cancer Inst (1987) 1.09
Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest (1984) 1.08
Circulating gastrin in peptic ulcer disease. Mt Sinai J Med (1973) 1.08
Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun (1996) 1.08
Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence. Peptides (1982) 1.08
Resting and pentagastrin-stimulated gastroesophageal sphincter pressure in patients with Zollinger-Ellison syndrome. Gastroenterology (1971) 1.08
Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience. J Natl Cancer Inst (1984) 1.08
Evaluating differences in survival between two groups of patients. J Chronic Dis (1971) 1.07
Regional cerebral blood flow during focal seizures of temporal and frontocentral onset. Ann Neurol (1990) 1.07
Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest (1987) 1.07
High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept (1981) 1.07
Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer (1986) 1.06
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine. Dig Dis Sci (1997) 1.06
Association of EB-virus infection with the post-perfusion syndrome. Lancet (1969) 1.05
Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol (1978) 1.05
Effect of gastric alkalinization on serum gastrin concentrations in humans. Gastroenterology (1983) 1.05
Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2000) 1.04
The space-time distribution of Hodgkin's disease in Connecticut, 1940-69. J Natl Cancer Inst (1973) 1.04
Somatostatin monoclonal antibody immunoneutralization increases gastrin and gastric acid secretion in urethane-anesthetized rats. Gastroenterology (1990) 1.04
Gastric acid secretory function in preterm infants. J Pediatr (1985) 1.04
Calcitonin gene-related peptide and spinal afferents partly mediate postoperative colonic ileus in the rat. Surgery (1998) 1.03
PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J Clin Invest (1999) 1.03
Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol (1990) 1.03